CAD 0.56
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -4.1 Million USD | 106.25% |
2022 | -14.67 Million USD | 1004.35% |
2021 | -2.29 Million USD | -133.75% |
2020 | 3.85 Million USD | 24.39% |
2019 | 3.51 Million USD | 321.56% |
2018 | -7.2 Million USD | -207.28% |
2017 | 2.29 Million USD | 15610.27% |
2016 | 8095.00 USD | -41.31% |
2015 | -10.47 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4.48 Million USD | 421.72% |
2024 Q1 | -644.19 Thousand USD | 35.94% |
2023 Q4 | 6.18 Million USD | -83.82% |
2023 Q1 | -1.18 Million USD | -104.03% |
2023 Q2 | -536.8 Thousand USD | 54.82% |
2023 FY | - USD | 106.25% |
2023 Q3 | 38.25 Million USD | 7226.33% |
2022 FY | - USD | 1004.35% |
2022 Q1 | -5.13 Million USD | 2.0% |
2022 Q3 | -1.74 Million USD | 5.73% |
2022 Q4 | 29.44 Million USD | 1785.33% |
2022 Q2 | -1.85 Million USD | 63.89% |
2021 Q1 | 5.17 Million USD | 690.81% |
2021 FY | - USD | -133.75% |
2021 Q2 | 1.16 Million USD | -77.46% |
2021 Q3 | -3.38 Million USD | -390.87% |
2021 Q4 | -5.23 Million USD | -54.51% |
2020 Q4 | 653.76 Thousand USD | -87.93% |
2020 Q3 | 5.41 Million USD | 527.01% |
2020 Q1 | 1.98 Million USD | 192.53% |
2020 Q2 | -1.26 Million USD | -163.86% |
2020 FY | - USD | 24.39% |
2019 Q4 | 678.81 Thousand USD | -51.39% |
2019 FY | - USD | 321.56% |
2019 Q3 | 1.39 Million USD | -38.36% |
2019 Q2 | 2.26 Million USD | 103.16% |
2019 Q1 | 1.11 Million USD | 156.44% |
2018 Q2 | -1.09 Million USD | -2186.15% |
2018 Q1 | -47.71 Thousand USD | -580.49% |
2018 Q3 | -60.14 Thousand USD | 94.49% |
2018 Q4 | -1.97 Million USD | -3184.66% |
2018 FY | - USD | -207.28% |
2017 Q2 | -4933.07 USD | -34.01% |
2017 FY | - USD | 15610.27% |
2017 Q1 | -3681.07 USD | 39.94% |
2017 Q3 | -606.19 USD | 87.71% |
2017 Q4 | -7012.33 USD | -1056.78% |
2016 Q3 | -6.85 USD | 0.0% |
2016 Q4 | -6129.01 USD | -89434.59% |
2016 FY | - USD | -41.31% |
2015 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 32.399% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -104.224% |
Blueberries Medical Corp. | -1.22 Million CAD | -236.057% |
The BC Bud Corporation | -1.19 Million CAD | -243.299% |
BioNxt Solutions Inc. | -6.48 Million CAD | 36.682% |
CordovaCann Corp. | -1.6 Million CAD | -156.2% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -56.508% |
Captor Capital Corp. | 2.42 Million CAD | 269.584% |
City View Green Holdings Inc. | -2.01 Million CAD | -103.822% |
1CM Inc. | 1.31 Million CAD | 412.587% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -16460.763% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -85.923% |
IM Cannabis Corp. | -2.79 Million CAD | -47.165% |
Lobe Sciences Ltd. | -4.4 Million CAD | 6.732% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -946.849% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -28.591% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 459.662% |
Ovation Science Inc. | -778.83 Thousand CAD | -427.188% |
Pharmadrug Inc. | -1.33 Million CAD | -207.556% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 32.202% |
RAMM Pharma Corp. | -6.3 Million CAD | 34.848% |
RIV Capital Inc. | -20.28 Million CAD | 79.754% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 26.615% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 94.708% |
SLANG Worldwide Inc. | -2.95 Million CAD | -39.15% |
1933 Industries Inc. | -10.03 Million CAD | 59.076% |
Red Light Holland Corp. | -5.25 Million CAD | 21.879% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -434.629% |
Xebra Brands Ltd. | -1.49 Million CAD | -174.644% |
Adastra Holdings Ltd. | -1.41 Million CAD | -190.938% |